SCHEMBL378029

SCHEMBL378029

Cc1cc(=O)n(-c2ccccc2)c2ccccc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.61
NQO2 P16083 1/20 0.61
KMT2A Q03164 3/20 0.55
MEN1 O00255 2/20 0.55
ATM Q13315 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
KDR P35968 1/20 0.52
MAPK8 P45983 2/20 0.47
PGR P06401 2/20 0.47
ALDH1A1 P00352 3/20 0.47
HPGD P15428 2/20 0.47
RECQL P46063 1/20 0.46
MAPK1 P28482 1/20 0.46
POLB P06746 1/20 0.44
TSHR P16473 1/20 0.44
BRCA1 P38398 1/20 0.44
HSD17B10 Q99714 1/20 0.44
HTR3E A5X5Y0 2/20 0.44
HTR3B O95264 2/20 0.44
HTR3A P46098 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8331649 0.87 KDM4E (0.54) KDM4ENQO2KMT2AMEN1ATM
SCHEMBL7494307 0.84 MAPT (0.56) KDM4ENQO2KMT2AMEN1ATM
SCHEMBL25042634 0.83 KDM4E (0.50) KDM4ENQO2KMT2AMEN1KDR
SCHEMBL9207981 0.81 KDM4E (0.51) KDM4ENQO2KMT2AMEN1ATM
SCHEMBL15828755 0.80 MEN1 (0.47) KDM4ENQO2KMT2AMEN1ATM
SCHEMBL3469530 0.80 KDM4E (0.50) KDM4ENQO2MAPK8ALDH1A1HPGD
SCHEMBL4618392 0.79 KDM4E (0.53) KDM4ENQO2KMT2AMEN1ATM
SCHEMBL4190262 0.79 ALDH1A1 (0.55) KDM4EKMT2AMEN1ATML3MBTL1
SCHEMBL7433737 0.76 HTR3E (0.54) KDM4EKMT2AMEN1ATML3MBTL1
SCHEMBL436564 0.76 KDM4E (1.00) KDM4ENQO2KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024081562-A1 DYES FOR NUCLEIC ACID DETECTION DETECT, INC. (US) 2024-04-18 WO disclosed
US-11667961-B2 Intercalating fluorescent dyes for labelling nucleic acids and preparation method thereof BIOACTS CORPORATION (KR) 2023-06-06 US disclosed
US-11667961-B2 Intercalating fluorescent dyes for labelling nucleic acids and preparation method thereof BIOACTS CORPORATION (KR) 2023-06-06 US disclosed
US-20210198729-A1 NOVEL INTERCALATING FLUORESCENT DYES FOR LABELLING NUCLEIC ACIDS AND PREPARATION METHOD THEREOF BIOACTS CORPORATION 2021-07-01 US disclosed
WO-2021105887-A1 SEPARATION AND ISOLATION OF NUCLEIC ACIDS USING AFFINITY LIGANDS BOUND TO A SOLID SURFACE EMP BIOTECH GMBH (DE) 2021-06-03 WO disclosed
US-20210155657-A1 SEPARATION AND ISOLATION OF NUCLEIC ACIDS USING AFFINITY LIGANDS BOUND TO A SOLID SURFACE EMP BIOTECH GMBH (DE) 2021-05-27 US disclosed
US-20200263231-A1 Fluorogenic dyes for high sensitivity DNA detection Life Technologies Corporation 2020-08-20 US disclosed
EP-2408863-B1 NUCLEIC ACID BINDING DYES AND USES THEREFOR PROMEGA CORP (US) 2018-01-10 EP disclosed
US-9682970-B2 Fluorescent compounds and uses thereof BIOTIUM, INC. (US) 2017-06-20 US disclosed
US-9458499-B2 Nucleic acid binding dyes and uses therefor PROMEGA CORPORATION (US) 2016-10-04 US disclosed
EP-0675924-B1 CYCLIC-SUBSTITUTED UNSYMMETRICAL CYANINE DYES MOLECULAR PROBES INC (US) 2001-12-12 EP disclosed
US-5658751-A SUBSTITUENTS ON PYRIDINIUM OR QUINOLINIUM RING SYSTEM SERVE TO INCREASE OR DECREASE PERMEABILITY, SELECTIVITY AND BINDING AFFINITY OF NUCLEIC ACID STAINS; FORM FLUORESCENT COMPLEXES WITH NUCLEIC ACIDS MOLECULAR PROBES, INC. (US) 1997-08-19 US disclosed
US-5545535-A USING MIXTURE OF FLUORESCENT DYES MOLECULAR PROBES, INC. (US) 1996-08-13 US disclosed
US-5534416-A ANALYZING CELL VIABILITY MOLECULAR PROBES, INC. (US) 1996-07-09 US disclosed
EP-0675924-A1 CYCLIC-SUBSTITUTED UNSYMMETRICAL CYANINE DYES MOLECULAR PROBES, INC. (US) 1995-10-11 EP disclosed
US-5445946-A Intravacuolar stains for yeast and other fungi MOLECULAR PROBES, INC. (US) 1995-08-29 US disclosed
US-5436134-A Fluorescent dyes for nucleic acids MOLECULAR PROBES, INC. (US) 1995-07-25 US disclosed
WO-1994024213-A1 CYCLIC-SUBSTITUTED UNSYMMETRICAL CYANINE DYES MOLECULAR PROBES, INC. (US) 1994-10-27 WO disclosed
US-4187310-A ANTIINFLAMMATORY AGENT, ANALGESICS, ENZYME INHIBITORS IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1980-02-05 US disclosed
US-4138490-A Analgesic compositions containing 1,2-dihydro-2-oxoquinol-4-ylpropionic acid derivatives IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1979-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210155657-A1 SEPARATION AND ISOLATION OF NUCLEIC ACIDS USING AFFINITY LIGANDS BOUND TO A SOLID SURFACE ADAR, SSBP1, POLRMT KDM4E 4308/4885NQO2 2818/4885KMT2A 2023/4885
US-20200263231-A1 Fluorogenic dyes for high sensitivity DNA detection POLRMT, POLM, DNMT3A KDM4E 3509/4885NQO2 73/4885KMT2A 1550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.